|
|
BSE |
NSE |
|
|
Products & Services > Corporate Action > Board Meetings |
 |
|
 |
01-Feb-23
|
Ajanta Pharma
| AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve unaudited consolidated & standalone financial results of the Company for the third quarter and nine months ended 31st December 2022. |
01-Feb-23
|
Alembic Pharma
| Quarterly Results |
01-Feb-23
|
Amarjothi Spg.
| AMARJOTHI SPINNING MILLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve - Intimation as per Regulation 29 of the SEBI (LODR) Regulations 2015 - Reg.
We would like to inform you that a Meeting of the Board of Directors of the Company will be held at the registered office of the Company on Wednesday the 01st of February 2023 to consider and take on record the Unaudited Financial Results for the quarter ended 31.12.2022 and any other matters with the consent of the Board.
Further as per the Companys Code of Conduct to Regulate Monitor and Reporting of Trading by Insiders adopted by Company Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for trading in the Companys Shares was closed for all specified persons of the Company on and from January 01 2023 till 48 hours after the declaration of financial results for the quarter ended 31st December 2022.
|
01-Feb-23
|
Aro Granite Inds
| ARO GRANITE INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve Audited Financial Results for the quarter ended 31.12.2022 |
01-Feb-23
|
Artemis Medicare
| Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve In pursuance of Regulation 29 and 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company will be held on February 1 2023 (Wednesday) inter-alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter/nine months period ended December 31 2022.
As informed by our communication dated December 30 2022 the trading window for dealing in securities of the Company was closed from January 1 2023 and shall remain closed till 48 hours after the declaration of financial results i.e. up to February 3 2023 (both days inclusive). |
01-Feb-23
|
Ashok Leyland
| ASHOK LEYLAND LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve the standalone and consolidated un-audited financial results of the Company for the quarter and nine months ended December 31 2022. |
01-Feb-23
|
Bandaram Pharma
| Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve Unaudited financial results for the quarter ended 31.12.2022 |
01-Feb-23
|
Bhageria Indust.
| Bhageria Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve the Unaudited Financial Results (i.e. Standalone and Consolidated) for the quarter ended December 31 2022 and any other business as may be considered fit and appropriate. |
01-Feb-23
|
Bharat Agri Fert
| BHARAT AGRI FERT & REALTY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the Board of Directors of the Company in their meeting scheduled on Wednesday 1st February 2023 shall inter-alia among others to consider the following matters:
1. Approval of Sub-division of Equity shares from the face value of Rs.10/- per share to Rs. 1/-per share.
2. Approval of alteration of capital clause of Memorandum of Association.
3. Any other business with the permission of the Chair.
Please take the above intimation on record and kindly acknowledge the receipt of the same.
Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company in their meeting scheduled on Wednesday, 1st February, 2023 shall inter-alia, among others, to consider the following matters: 1. Approval of Sub-division of Equity shares from the face value of Rs.10/- per share to Rs. 1/-per share. 2. Approval of alteration of capital clause of Memorandum of Association. Please take the above intimation on record and kindly acknowledge the receipt of the same. |
01-Feb-23
|
Bijoy Hans
| BIJOY HANS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve a) the unaudited financial results of the Company for the quarter and nine months ended 31st December 2022.
b) appointment of Secretarial Auditor of the Company for the financial year 2022-23. |
|
|
|
|
|
 |
|